Research Article| Volume 27, ISSUE 1, P77-83, May 1997

A comparative study of an estradiol-releasing vaginal ring versus tibolone in postmenopausal women: a transvaginal color Doppler study

      This paper is only available as a PDF. To read, Please Download here.


      Objective: To evaluate endometrial blood flow characteristics in response to estrogen replacement therapy (ERT) and tibolone in postmenopausal women and to correlate the resistance index (RI) with plasma estradiol levels. Materials and methods: Transvaginal color Doppler ultrasound examinations were performed in 72 asymptomatic, postmenopausal women who demonstrated endometrial thickness ≤ 5 mm. Thirty-six women receiving tibolone and 36 patients receiving ERT by a vaginal ring comprised the study groups. Results: All postmenopausal women treated with tibolone or ERT showed continuous forward end-diastolic flow. The lowest RI was obtained in women with the vaginal ring inserted. The plasma concentrations of estradiol were found to be significantly higher in the vaginal ring group than those of tibolone. Conclusions: The data observed suggest that ERT and tibolone modify normal postmenopausal endometrial perfusion. Tibolone had a weaker estrogenic effect on endometrial blood flow resistance, and vaginal ring treatment enhanced endometrial blood perfusion through vasodilatation.


      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to Maturitas
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • Josif CS
        • Benassy Z
        Prevalence of genito-urinary symptoms in the late menopause.
        Acta Obstet Gynecol Scand. 1984; 63: 257-260
        • Mettler L
        • Olsen PG
        Vaginal administration of low dose estradiol. Safety and efficiency in long-term treatment of atrophic vaginitis.
        Maturitas. 1991; 14: 23-31
        • Maudel FP
        • Geola FL
        • Meldnum DR
        • Lu JHK
        • Eggns P
        • Sambin M der P
        • Hershman JM
        • Judd HL
        Biological effects of various doses of vaginally administered conjugated estrogens in postmenopausal women.
        J Clin Endocrinol Metabol. 1983; 57: 133
        • Genazzani AR
        • et al.
        Org OD 14 and the endometrium.
        Maturitas. 1991; 13: 243-251
        • Trevoux R
        • Dieulangard P
        • Blum A
        Efficacy and safety of ORG OD 14 in the treatment of climacteric complaints.
        Maturitas. 1983; : 89-96
        • Bourne TH
        • Campbell S
        • Whitehead MI
        • Royston P
        • Steer CV
        • Collins WP
        Detection of endometrial cancer in postmenopausal women by transvaginal ultrasonography and color flow imaging.
        Br Med J. 1990; 299: 369-373
        • Kurjak A
        • Shalan H
        • Sosic A
        • Benic S
        • Zudenigo D
        • Kupesic S
        • Predanic M
        Endometrial carcinoma in postmenopausal women: evaluation by transvaginal color Doppler ultrasonography.
        Am J Obstet Gynecol. 1993; 169: 1597-1603
        • Schmidt G
        • Andersson S-B
        • Nordle O
        • Johansson C-J
        • Gunnarsson PO
        Release of 17-beta-Oestradiol from a vaginal ring in postmenopausal women: pharmacokinetic evaluation.
        Gynecol Obstet Invest. 1994; 38: 253-260
        • Stumpf PG
        • Maruca J
        • Sauten RJ
        • Demers L
        Development of a vaginal ring for achieving physiologic levels of 17β-estradiol in hypoestrogenic women.
        J Clin Endocrinol Metab. 1982; 54: 208-210
        • Holmgren PA
        • Lindskog M
        • von Schoultz B
        Vaginal rings for continuous low-dose release of oestradiol in treatment of urogenital atrophy.
        Maturitas. 1989; 11: 55-63
        • Smith P
        • Heimer G
        • Lindskog M
        • Ulmsten U
        Estradiolreleasing vaginal ring for treatment of postmenopausal urogenital atrophy.
        Maturitas. 1993; 16: 145-154
        • Narsi MN
        • Shepherd JH
        • Setchell ME
        • et al.
        The role of vaginal scan in measurement of endometrial thickness in postmenopausal women.
        Br J Obstet Gynaecol. 1991; 98: 470-475
        • Varner RE
        • Sparks JM
        • Cameron CD
        • Roberts LL
        • Soong S-J
        Transvaginal sonography of the endometrium in postmenopausal women.
        Obstet Gynecol. 1991; 78: 195
        • Holbert TR
        Screening transvaginal ultrasonography of postmenopausal women in a private office setting.
        Am J Obstet Gynecology. 1994; 170: 1699-1704
        • Andersson SB
        Development pharmaceutics of an estradiol-releasing vaginal silicone ring.
        in: research report no 20230 F. Kabi Pharmacia AB, Uppsala, Sweden1992
        • Martin PL
        • Yen SSC
        • Burnier AAM
        • Hermann H
        Systemic absorption and sustained effects on vaginal estrogen creams.
        J Am Med Assoc. 1979; 242: 2699-2700
        • Hargrove JT
        • Maxson WS
        • Colston WA
        • Burnett LS
        Menopausal hormone replacement therapy with continuous daily oral micronized estradiol and progesterone.
        Obstet Gynecol. 1989; 73: 606-612
        • Gerbaldo D
        • Ferraiolo A
        • Crose S
        • Trinini M
        • Capitano GL
        Endometrial morphology after 12 months of vaginal oestriol therapy in postmenopausal women.
        Maturitas. 1991; 13: 269-274
        • Wildholm O
        • Vartiainen E
        The absorption of conjugated oestrogen and sodium oestrone sulfate from the vagina.
        Ann Chir Gynaecol Fenn. 1974; 63: 186-190
        • Luisi M
        • Franchi F
        • Kicovic PM
        A group-comparative study of effects of Ovestin cream versus Premarin cream in postmenopausal women with vaginal atrophy.
        Maturitas. 1980; 2: 309-311
        • Van der Vies J
        Pharmacological studies with ORG OD 14.
        Maturitas. 1987; : 25
        • Benedek-Jaszman LJ
        Long-term placebo-controlled efficacy and safety study of ORG OD 14 in climacteric women.
        Maturitas. 1987; : 25-33
        • Tax L
        • Goorissen EM
        • Kieovic PM
        Clinical profile of Org OD 14.
        Maturitas. 1987; : 3-13
        • Rosenfeld CR
        • Jackson GM
        Induction and inhibition of uterine vasodilatation by catechol estrogen in oophorectomized non pregnant ewes.
        Endocrinology. 1982; 110: 1333-1339
        • Rosenfeld CR
        • Morris FJ
        • Battaglia FC
        • Makowski EL
        • Meschia G
        Effect of estradiol on blood flow to reproductive and non reproductive tissues in pregnant ewes.
        Am J Obstet Gynecol. 1976; 124: 618-629
        • Mangness RR
        • Rosenfeld CR
        The role of steroid hormones in the control futerine blood flow.
        in: Rosenfeld CR The Uterine blood flow. Perinatology Press, New York1989: 239-271
        • Hafez ESE
        The vagina and human reproduction.
        Am J Obstet Gynecol. 1977; 129: 573-584
        • Trevoux R
        • van der Welden WH
        • Popovic D
        Ovestin vaginal cream and suppositories for the treatment of menopausal vaginal atrophy.
        Reproduction. 1982; 6: 101-106
        • Raz R
        • Stamm WE
        A controlled trial of intra-vaginal estriol in postmenopausal women with recurrent urinary tract infections.
        New Engl J Med. 1993; 329: 753-756
        • Carlstrom K
        • Karlgren E
        • Furuhjelm M
        Effects of intravaginal oestrogen treatment upon the vaginal absorption of conjugated equine oestrogens.
        Maturitas. 1982; 4: 277-283
        • Kurjak A
        • Shalan H
        • Kupesic S
        • Predanic M
        • Zalud I
        • Breyer B
        • Jukics S
        Transvaginal color Doppler sonography in the assessment of pelvic tumor vascularity.
        Ultrasound Obstet Gynecol. 1993; 3: 137-154
        • Merce LT
        • Lopez-Garcia G
        • De la Feunte F
        Doppler ultrasound assessment of the endometrial pathology.
        Acta Obstet Gynecol Scand. 1991; 70: 525-530
        • Achiron R
        • Lipitz S
        • Frenuel Y
        • Mashiach S
        Endometrial blood flow response to estrogen replacement therapy and tamoxifen in asymptomatic, postmenopausal women: a transvaginal Doppler study.
        Ultrasound Obstet Gynecol. 1995; 5: 411-414